Kelly Financial Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-50
| Closed | -$4 | – | 820 |
|
|
2023
Q3 | $4 | Hold |
50
| – | – | ﹤0.01% | 764 |
|
|
2023
Q2 | $5 | Hold |
50
| – | – | ﹤0.01% | 723 |
|
|
2023
Q1 | $13 | Hold |
50
| – | – | ﹤0.01% | 699 |
|
|
2022
Q4 | $11 | Hold |
50
| – | – | ﹤0.01% | 687 |
|
|
2022
Q3 | $13 | Hold |
50
| – | – | ﹤0.01% | 698 |
|
|
2022
Q2 | $36 | Hold |
50
| – | – | ﹤0.01% | 677 |
|
|
2022
Q1 | $40 | Hold |
50
| – | – | ﹤0.01% | 669 |
|
|
2021
Q4 | $50 | Hold |
50
| – | – | ﹤0.01% | 674 |
|
|
2021
Q3 | $88 | Sell |
50
-42
| -46% | -$74 | ﹤0.01% | 638 |
|
|
2021
Q2 | $50K | Buy |
92
+42
| +84% | +$22.8K | ﹤0.01% | 462 |
|
|
2021
Q1 | $101 | Hold |
50
| – | – | ﹤0.01% | 626 |
|
|
2020
Q4 | $108 | Hold |
50
| – | – | ﹤0.01% | 582 |
|
|
2020
Q3 | $135 | Hold |
50
| – | – | ﹤0.01% | 560 |
|
|
2020
Q2 | $197 | Hold |
50
| – | – | ﹤0.01% | 569 |
|
|
2020
Q1 | $38 | Hold |
50
| – | – | ﹤0.01% | 570 |
|
|
2019
Q4 | $63 | Hold |
50
| – | – | ﹤0.01% | 551 |
|
|
2019
Q3 | $35 | Hold |
50
| – | – | ﹤0.01% | 547 |
|
|
2019
Q2 | $32 | Hold |
50
| – | – | ﹤0.01% | 496 |
|
|
2019
Q1 | $138 | Buy |
+50
| New | +$138 | ﹤0.01% | 479 |
|